- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Hwang, W.Y., Koh, L.P., Ng, H.J., Tan, P.H., Chuah, C.T., Fook, S.C., Chow, H., Tan, K.W., Wong, C., Tan, C.H., Goh, Y.T. Bone Marrow Transplant. (2004)